The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.
Yafei YouChang JiangKunwei PengWenzhuo HeLei WangYanan JinLiang-Ping XiaPublished in: Cancer immunology, immunotherapy : CII (2021)
In general, high BMI was correlated with improved OS and PFS in patients treated with immunotherapy along with a high risk of irAEs. However, discrepant findings from subgroup analyses urgently call for further analysis.